Trudy Oliver
Affiliations: | Pharmacology | Duke Medical School, Durham, NC, United States |
Google:
"Trudy Oliver"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Finlay JB, Ireland AS, Hawgood SB, et al. (2024) Olfactory neuroblastoma mimics molecular heterogeneity and lineage trajectories of small-cell lung cancer. Cancer Cell |
| Weber MC, Izzo LT, Oliver TG. (2023) Epigenetic Regulators Open the Door to SCLC Plasticity. Cancer Research. 83: 3495-3497 |
| Pearsall SM, Williamson SC, Humphrey S, et al. (2023) Lineage plasticity in SCLC generates non-neuroendocrine cells primed for vasculogenic mimicry. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
| Chen H, Gesumaria L, Park YK, et al. (2022) BET Inhibitors Target the SCLC-N subtype of Small Cell Lung Cancer by Blocking NEUROD1 Transactivation. Molecular Cancer Research : McR |
| Groves SM, Ildefonso GV, McAtee CO, et al. (2022) Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancer. Cell Systems |
| Kelenis DP, Rodarte KE, Kollipara RK, et al. (2022) Inhibition of karyopherin β1-mediated nuclear import disrupts oncogenic lineage- defining transcription factor activity in small cell lung cancer. Cancer Research |
| Hamad SH, Montgomery SA, Simon JM, et al. (2022) TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice. Oncogene |
| Sutherland KD, Ireland AS, Oliver TG. (2022) Killing SCLC: insights into how to target a shapeshifting tumor. Genes & Development. 36: 241-258 |
| Cargill KR, Stewart CA, Park EM, et al. (2021) Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer. Cancer & Metabolism. 9: 33 |
| Pe'er D, Ogawa S, Elhanani O, et al. (2021) Tumor heterogeneity. Cancer Cell. 39: 1015-1017 |